Form4insider filings, from the source

SEC Form 4 · accession 0000899243-16-016036

Emergent BioSolutions Inc. · EBS

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Fuad El-Hibri
Officer — Chairman · Director · 10% Owner
Period of report
Mar 11, 2016
Accepted (ET)
Mar 15, 2016 · 7:16 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367644

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Mar 11, 2016M6,967—A1,800,975D
Common StockMar 11, 2016F1,902$34.22D1,799,073D
Common StockF2holding———2,350,331IBy Intervac, L.L.C.
Common StockF3holding———1,524,155IBy Biovac, L.L.C.

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restrictive Stock UnitsF1,F4—Mar 11, 2016M6,967D——Common Stock6,96769,196D

Explanation of responses